Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities:
Net loss	$ (7,537,845)	$ (6,914,992)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	551,092	560,801
Amortization	39,976	118,852
Amortization of discount on investments	0	(1,189)
Amortization of right-of-use assets	373,219	421,111
Inventory reserve	540	5,800
Share-based compensation expense	193,366	318,640
Loan and accrued interest forgiveness on note payable	(821,515)	0
Loss on fixed asset disposition	3,098	0
Changes in operating assets and liabilities:
Accounts receivable	41,532	(42,236)
Inventory	(77,432)	35,319
Other assets	475,993	79,442
Accounts payable	(228,811)	80,755
Accrued expenses and other	(504,799)	765,421
Lease liabilities	(413,212)	(445,733)
Other liabilities	(25,987)	84,994
Net cash used in operating activities	(7,930,785)	(4,933,015)
Cash flows from investing activities:
Maturities of short-term investments	0	1,000,000
Purchases of furniture and equipment	(306,868)	(8,352)
Payments for patents and other intangible assets	0	(23,329)
Net cash (used in) provided by investing activities	(306,868)	968,319
Cash flows from financing activities:
Payments of deferred offering costs	(1,578,643)	(75,000)
Proceeds from issuance of common stock	31,740,046	153,200
Proceeds from note payable	0	812,500
Repayment of note payable	(442,086)	0
Payments under lease obligations	(20,861)	(19,052)
Net cash provided by financing activities	29,698,456	871,648
Net change in cash and cash equivalents	21,460,803	(3,093,048)
Cash and cash equivalents:
Beginning of year	3,322,226	6,415,274
End of year	24,783,029	3,322,226
Cash paid for:
Interest	15,865	6,900
Income taxes	800	2,000
Non-cash investing and financing activities:
Conversion of convertible preferred stock to common stock	55,360,897	0
Deferred offering costs included in accounts payable and accrued expenses	0	127,479
Prepaid insurance financed with promissory notes	$ 181,123	$ 0